ALLIANCEBERNSTEIN L.P. - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 57 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,818,304
+97.1%
61,140
+19.4%
0.00%
Q2 2023$922,624
+12.2%
51,2000.0%0.00%
Q1 2023$822,272
-12.2%
51,2000.0%0.00%
Q4 2022$936,960
-6.9%
51,2000.0%0.00%
Q3 2022$1,006,000
+5.3%
51,2000.0%0.00%
Q2 2022$955,000
+46.9%
51,200
+73.0%
0.00%
Q1 2022$650,000
-22.4%
29,600
+0.3%
0.00%
Q4 2021$838,000
+34.9%
29,5000.0%0.00%
Q3 2021$621,000
+11.7%
29,5000.0%0.00%
Q2 2021$556,000
+35.6%
29,500
+10.1%
0.00%
Q1 2021$410,000
+4.1%
26,800
-3.9%
0.00%
Q4 2020$394,000
-3.0%
27,900
+7.7%
0.00%
Q3 2020$406,000
-10.6%
25,9000.0%0.00%
Q2 2020$454,000
+108.3%
25,900
+75.0%
0.00%
Q1 2020$218,000
-26.4%
14,800
+25.4%
0.00%
Q4 2019$296,000
+76.2%
11,800
+5.4%
0.00%
Q3 2019$168,000
-25.3%
11,200
+24.4%
0.00%
Q2 2019$225,0009,0000.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,375,169$84,379,0007.91%
RA Capital Management 1,875,209$46,880,0002.52%
Perceptive Advisors 2,587,953$64,698,0001.48%
New Leaf Venture Partners, L.L.C. 167,700$4,193,0001.12%
Orbimed Advisors 2,039,282$50,982,0000.79%
Eventide Asset Management 803,839$20,096,0000.61%
Novo Holdings A/S 135,009$3,375,0000.47%
Opaleye Management Inc. 36,000$900,0000.27%
ADAGE CAPITAL PARTNERS GP, L.L.C. 490,000$12,250,0000.03%
Baker Brothers Advisors 132,985$3,325,0000.02%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders